Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
141.03
+6.24 (4.63%)
At close: Nov 4, 2026, 4:00 PM EST
141.05
+0.02 (0.01%)
Pre-market: Nov 5, 2026, 4:48 AM EST
Encompass Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,338 | 5,935 | 5,373 | 4,801 | 4,349 | 4,015 | |
Revenue Growth | 9.36% | 10.46% | 11.91% | 10.41% | 8.31% | 12.58% |
Cost of Revenue | 3,540 | 3,370 | 3,140 | 2,818 | 2,595 | 2,312 |
Gross Profit | 2,798 | 2,565 | 2,233 | 1,983 | 1,753 | 1,703 |
Selling, General & Admin | 313.8 | 300.5 | 272.3 | 264.1 | 209 | 228.5 |
Other Operating Expenses | 963 | 883.4 | 786.4 | 713 | 670.4 | 595.9 |
Operating Expenses | 1,637 | 1,512 | 1,358 | 1,251 | 1,123 | 1,044 |
Operating Income | 1,161 | 1,053 | 874.9 | 731.8 | 630.2 | 659.4 |
Interest Expense | -127 | -123.2 | -137.4 | -143.5 | -175.7 | -164.3 |
Earnings From Equity Investments | 1.4 | 4.3 | 3 | 3.2 | 2.9 | 3.4 |
Other Non Operating Income (Expenses) | 33.4 | 18.8 | 20.1 | 15.7 | -5.2 | 7.5 |
EBT Excluding Unusual Items | 1,069 | 953 | 760.6 | 607.2 | 452.2 | 506 |
Merger & Restructuring Charges | - | - | -10.4 | - | - | - |
Other Unusual Items | -3.4 | - | -0.6 | - | -1.4 | -1 |
Pretax Income | 1,066 | 953 | 749.6 | 607.2 | 450.8 | 505 |
Income Tax Expense | 218.8 | 192.9 | 150.2 | 132.2 | 100.1 | 101.9 |
Earnings From Continuing Operations | 847 | 760.1 | 599.4 | 475 | 350.7 | 403.1 |
Earnings From Discontinued Operations | 15.3 | -1 | -2.8 | -12 | 13.9 | 112.3 |
Net Income to Company | 862.3 | 759.1 | 596.6 | 463 | 364.6 | 515.4 |
Minority Interest in Earnings | -217.9 | -192.9 | -140.9 | -111 | -93.6 | -103.2 |
Net Income | 644.4 | 566.2 | 455.7 | 352 | 271 | 412.2 |
Preferred Dividends & Other Adjustments | 1.5 | 1.5 | 2.8 | 2.4 | 1.2 | 1.8 |
Net Income to Common | 642.9 | 564.7 | 452.9 | 349.6 | 269.8 | 410.4 |
Net Income Growth | 19.25% | 24.69% | 29.55% | 29.58% | -34.26% | 44.91% |
Shares Outstanding (Basic) | 99 | 101 | 100 | 100 | 99 | 99 |
Shares Outstanding (Diluted) | 101 | 102 | 102 | 101 | 100 | 100 |
Shares Change | -1.61% | - | 0.89% | 0.90% | 0.20% | 0.40% |
EPS (Basic) | 6.48 | 5.62 | 4.53 | 3.51 | 2.72 | 4.15 |
EPS (Diluted) | 6.40 | 5.54 | 4.46 | 3.47 | 2.70 | 4.11 |
EPS Growth | 20.98% | 24.25% | 28.32% | 28.73% | -34.39% | 44.46% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 457.2 | 439.2 | 360.3 | 267.7 | 121.7 | 170.1 |
Free Cash Flow Per Share | 4.54 | 4.30 | 3.52 | 2.64 | 1.21 | 1.70 |
Dividend Per Share | 0.780 | 0.720 | 0.640 | 0.600 | 0.860 | 1.120 |
Dividend Growth | 11.43% | 12.50% | 6.67% | -30.23% | -23.21% | 0% |
Gross Margin | 44.15% | 43.21% | 41.56% | 41.30% | 40.32% | 42.43% |
Operating Margin | 18.32% | 17.74% | 16.28% | 15.24% | 14.49% | 16.42% |
Profit Margin | 10.14% | 9.51% | 8.43% | 7.28% | 6.20% | 10.22% |
Free Cash Flow Margin | 7.21% | 7.40% | 6.71% | 5.58% | 2.80% | 4.24% |
EBITDA | 1,521 | 1,381 | 1,175 | 1,006 | 873.8 | 879 |
EBITDA Margin | 24.00% | 23.27% | 21.86% | 20.95% | 20.09% | 21.89% |
D&A For EBITDA | 359.8 | 327.9 | 299.6 | 273.9 | 243.6 | 219.6 |
EBIT | 1,161 | 1,053 | 874.9 | 731.8 | 630.2 | 659.4 |
EBIT Margin | 18.32% | 17.74% | 16.28% | 15.24% | 14.49% | 16.42% |
Effective Tax Rate | 20.53% | 20.24% | 20.04% | 21.77% | 22.20% | 20.18% |
Advertising Expenses | - | 5.3 | 5.8 | 6.1 | 6.3 | 5.6 |